Structure (Image 1)
Doxazosin Tablet
Product Images NDC 71335-2803
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71335-2803). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Image 2)
This document appears to present results from several studies evaluating the maximum flow rate and symptom scores of participants taking placebo and doxazosin mesylate for a certain condition, possibly related to the urinary tract. The studies include baseline measurements and changes after treatment with different doses of doxazosin mesylate over varying periods. The results are presented numerically, showing the mean maximum flow rate, symptom scores, and any changes observed. The document also mentions questionnaires used in the studies and provides information on the dosage and timing of assessments. Additionally, it includes a note about the statistical significance of the results when compared to the placebo group.*
1 (Image 3)
The text provides information on the mean change in total symptom score from baseline and the mean increase in maximum urinary flow rate in a study involving 47 participants. The results show a decrease in symptoms and an increase in urinary flow rate throughout the treatment duration of up to 14 weeks. Additionally, doxazosin was titrated to a maximum dosage of 8 mg. The study compared the results to the placebo group and baseline values, highlighting statistically significant differences.*
Label (Lbl713352803)
This is a description of a medication called Doxazosin Tablets USP. Each tablet contains 1mg of Doxazosin Mesylate USP. The text provides instructions to keep the medication out of the reach of children and store it at a temperature range of 20°C to 25°C. It also mentions that the tablets should be dispensed in a well-closed container. The medication is packed by Bryant Ranch Prepack, Inc. and manufactured by Piramal Pharma Limited. The text includes a National Drug Code (NDC) for identification purposes. The pharmacist is instructed to dispense the patient package inserts.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
